MedPath

Outcome of hematopoietic stem cell transplantation in pediatric patient with Thalassemia in Thailand

Recruiting
Conditions
Transfusion dependent thalassemia receiving hematopoietic stem cell transplantaton
Hematopoietic stem cell transplantation, thalassemia, pediatric, outcome, Thailand
Registration Number
TCTR20220905001
Lead Sponsor
The Thai Society of Hematology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
350
Inclusion Criteria

1. All severe thalassemia patients who have undergone allogeneic stem cell transplantation between 1st July 1988 - 30th April 2016
2. Age 1-20 years at the time of hematopoietic stem cell transplantation

Exclusion Criteria

Haploidenical transplantation

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome of treatment At 5 years after date of transplantation Kaplan-Meier
Secondary Outcome Measures
NameTimeMethod
Complication of treatment At 5 years after date of transplantation Univariate and multivariate analysis
© Copyright 2025. All Rights Reserved by MedPath